+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

2019 Genital Warts (Condylomata Acuminata) Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

  • ID: 4767441
  • Report
  • April 2019
  • Region: Global
  • 73 pages
  • VPA Research
1 of 3

FEATURED COMPANIES

  • Aviragen Therapeutics Inc
  • BioMAS Ltd
  • Gilead Sciences Inc
  • MediGene AG
  • Merck & Co Inc
  • Novan Inc
  • MORE
The global clinical trial report- “2019 Genital Warts (Condylomata Acuminata) Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Genital Warts (Condylomata Acuminata). It presents in-depth analysis of Genital Warts (Condylomata Acuminata) clinical trials across markets and companies. The research work is for providing complete understanding into trends in Genital Warts (Condylomata Acuminata).

The report covers a key snapshot of trial trends, enrollment trends, success trends, locations and other trends.

It also segments the Genital Warts (Condylomata Acuminata) clinical trials by:
  • Current Trial Status
  • Type of the trial
  • Sponsor Type
  • Enrollment Trends
  • Region
  • Countries
  • Trial Phase
The report also identifies the potential drug candidates under development for treatment of Genital Warts (Condylomata Acuminata)

The research work is prepared through extensive and continuous research on Genital Warts (Condylomata Acuminata) trials from over 1500 sources including company websites, conferences and presentations, scientific journals, country wise and global clinical trial registries, news, health and science departments among others.

Report Scope and Coverage:
  • All major trials from 2010 to 2019 and planned trials are included in the report scope.
  • Drug candidates currently being researched for administering Genital Warts (Condylomata Acuminata) patients are identified
  • The report includes panorama of Genital Warts (Condylomata Acuminata) clinical trials across the globe
  • Trial Phase, Current Status, Sponsor Type, Location, trial type and Enrollment details are provided
  • Companies and universities focusing on Genital Warts (Condylomata Acuminata) clinical trials are analyzed along with their trial participation (trial title, trial phase and current status)
  • Average Enrollment number, insights into enrollment trends, company wise enrollment are included
  • Both interventional and observational studies are analyzed
  • News and latest developments for the past one year are presented in the report
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Aviragen Therapeutics Inc
  • BioMAS Ltd
  • Gilead Sciences Inc
  • MediGene AG
  • Merck & Co Inc
  • Novan Inc
  • MORE
1.1 List of Figures
1.2 List of Tables

2. Executive Summary
2.1 Genital Warts (Condylomata Acuminata) Clinical Trials Overview, 2019
2.2 Premium Insights into Clinical Trials
2.2.1 Genital Warts (Condylomata Acuminata) Clinical Trials by Region
2.2.2 Average Enrollment of Genital Warts (Condylomata Acuminata) Clinical Trials
2.2.3 Companies participating in Trials
2.2.4 Drugs under Study for Genital Warts (Condylomata Acuminata) Treatment, 2019

3. Region wise Genital Warts (Condylomata Acuminata) Clinical Trials
3.1 Asia Pacific Genital Warts (Condylomata Acuminata) Clinical Trials by Country
3.2 Europe Genital Warts (Condylomata Acuminata) Clinical Trials by Country
3.3 North America Genital Warts (Condylomata Acuminata) Clinical Trials by Country
3.4 Middle East and Africa Genital Warts (Condylomata Acuminata) Clinical Trials by Country
3.5 South and Central America Genital Warts (Condylomata Acuminata) Clinical Trials by Country

4. Genital Warts (Condylomata Acuminata) Clinical Trial Trends
4.1 Start Year wise Genital Warts (Condylomata Acuminata) Clinical Trials
4.2 Phase wise Genital Warts (Condylomata Acuminata) Clinical Trials
4.3 Trial Status wise Genital Warts (Condylomata Acuminata) Clinical Trials
4.4 Trial Type wise Genital Warts (Condylomata Acuminata) Clinical Trials

5. Genital Warts (Condylomata Acuminata) Average Enrollment Trends
5.1 Average Enrollment in Genital Warts (Condylomata Acuminata) Trials by Year
5.2 Average Enrollment in Genital Warts (Condylomata Acuminata) Trials by Phase
5.3 Average Enrollment in Genital Warts (Condylomata Acuminata) Trials by Status
5.4 Average Enrollment in Genital Warts (Condylomata Acuminata) Trials by Type of Trial

6. Companies Participating in Genital Warts (Condylomata Acuminata) Clinical Trials
6.1 Genital Warts (Condylomata Acuminata) Trials by Sponsor Type
6.2 Genital Warts (Condylomata Acuminata) Average Enrollment by Sponsor Type
6.3 Subjects Recruited by Leading Sponsors

7. Trial Snapshots- Phase, Type, Title, Location, Start Year, Completion Year, Recruitment Status, Enrollment, Participating Countries, Trial Locations, Company, Drugs and Other Details
7.1 Genital Warts (Condylomata Acuminata) Trials- Phase 1
7.2 Genital Warts (Condylomata Acuminata) Trials- Phase 2
7.3 Genital Warts (Condylomata Acuminata) Trials- Phase 3
7.4 Genital Warts (Condylomata Acuminata) Trials- Phase 4

8. Appendix
8.1 Report Guidance
8.2 Research Methodology
8.3 Abbreviations
8.4 Definitions
8.5 Sources
8.6 Publisher Expertise

List of Figures
Figure 1: Genital Warts (Condylomata Acuminata) Clinical Trials by Region, 2019
Figure 2: Country wise Clinical Trials, 2019
Figure 3: Country wise Average Enrolment, 2019
Figure 4: Asia Pacific - Country wise Genital Warts (Condylomata Acuminata) Clinical Trials and Enrolment
Figure 5: Europe - Country wise Genital Warts (Condylomata Acuminata) Clinical Trials and Enrolment
Figure 6: Middle East Africa - Country wise Genital Warts (Condylomata Acuminata) Clinical Trials and Enrolment
Figure 7: North America - Country wise Genital Warts (Condylomata Acuminata) Clinical Trials and Enrolment
Figure 8: South and Central America - Country wise Genital Warts (Condylomata Acuminata) Clinical Trials and Enrolment
Figure 9: Genital Warts (Condylomata Acuminata) Clinical Trials by Phase
Figure 10: Genital Warts (Condylomata Acuminata) Clinical Trials by Trial Status
Figure 11: Genital Warts (Condylomata Acuminata) Clinical Trials by Type
Figure 12: Genital Warts (Condylomata Acuminata) Clinical Trials by Sponsor Type
Figure 13: Genital Warts (Condylomata Acuminata) Clinical Trials by Leading Sponsors
Figure 14: Genital Warts (Condylomata Acuminata) Average Enrollment by Phase
Figure 15: Genital Warts (Condylomata Acuminata) Average Enrollment by Trial Status
Figure 16: Genital Warts (Condylomata Acuminata) Average Enrollment by Type
Figure 17: Genital Warts (Condylomata Acuminata)- Average Enrolment by Type of Sponsors
Figure 18: Genital Warts (Condylomata Acuminata)- Enrolment by Leading Sponsors
Figure 19: Research Methodology

List of Tables
Table 1: Genital Warts (Condylomata Acuminata) Clinical Trials Snapshot- 2019
Table 2: Trials by Region, 2019
Table 3: Country wise Clinical Trials and Average Enrolment by Country, 2019
Table 4: Asia Pacific - Country wise Genital Warts (Condylomata Acuminata) Clinical Trials and Enrolment
Table 5: Europe - Country wise Genital Warts (Condylomata Acuminata) Clinical Trials and Enrolment
Table 6: Middle East Africa - Country wise Genital Warts (Condylomata Acuminata) Clinical Trials and Enrolment
Table 7: North America - Country wise Genital Warts (Condylomata Acuminata) Clinical Trials and Enrolment
Table 8: South and Central America - Country wise Genital Warts (Condylomata Acuminata) Clinical Trials and Enrolment
Table 9: Clinical Trials by Phase
Table 10: Clinical Trials by Trial Status
Table 11: Clinical Trials by Type
Table 12: Clinical Trials by Sponsor Type
Table 13: Clinical Trials by Leading Sponsors
Table 14: Genital Warts (Condylomata Acuminata) Average Enrollment by Phase
Table 15: Genital Warts (Condylomata Acuminata) Average Enrollment by Trial Status
Table 16: Genital Warts (Condylomata Acuminata) Average Enrollment by Type
Table 17: Genital Warts (Condylomata Acuminata)- Average Enrolment by Type of Sponsors
Table 18: Genital Warts (Condylomata Acuminata)- Enrolment by Leading Sponsors
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Aviragen Therapeutics Inc
  • Beijing Wantai Biological Pharmacy Enterprise Co Ltd
  • BioMAS Ltd
  • G&E Herbal Biotechnology Co Ltd
  • Gilead Sciences Inc
  • Graceway Pharmaceuticals LLC
  • MediGene AG
  • Merck & Co Inc
  • Novan Inc
  • Novartis AG
Note: Product cover images may vary from those shown
Adroll
adroll